BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9491843)

  • 21. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
    N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature.
    Jossi M; Ambrosioni J; Macedo-Vinas M; Garbino J
    Int J Infect Dis; 2010 Apr; 14(4):e354-6. PubMed ID: 19665409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
    Olivares R; Luppi M; Díaz MC
    Rev Chilena Infectol; 2018 Aug; 35(4):448-452. PubMed ID: 30534934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of Acremonium fungemia with voriconazole.
    Mattei D; Mordini N; Lo Nigro C; Gallamini A; Osenda M; Pugno F; Viscoli C
    Mycoses; 2003 Dec; 46(11-12):511-4. PubMed ID: 14641626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
    Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J
    Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhodotorula fungemia: two cases and a brief review.
    Duggal S; Jain H; Tyagi A; Sharma A; Chugh TD
    Med Mycol; 2011 Nov; 49(8):879-82. PubMed ID: 21595509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhodotorula rubra fungaemia in an immunosuppressed patient.
    Papadogeorgakis H; Frangoulis E; Papaefstathiou C; Katsambas A
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):169-70. PubMed ID: 10343949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia.
    Liang DC; Chen SH; Lean SF
    Am J Hematol; 1995 Feb; 48(2):76-81. PubMed ID: 7531394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection.
    Bodey GP; Anaissie E; Gutterman J; Vadhan-Raj S
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S18-22. PubMed ID: 7875147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation.
    Abdala E; Lopes RI; Chaves CN; Heins-Vaccari EM; Shikanai-Yasuda MA
    Transpl Infect Dis; 2005; 7(3-4):162-5. PubMed ID: 16390408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of invasive fungal infections.
    Kullberg BJ; de Pauw BE
    Neth J Med; 1999 Sep; 55(3):118-27. PubMed ID: 10509070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
    Flynn TN; Kelsey SM; Hazel DL; Guest JF
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichosporon beigelii infection: experience in a regional burn center.
    Cawley MJ; Braxton GR; Haith LR; Reilly KJ; Guilday RE; Patton ML
    Burns; 2000 Aug; 26(5):483-6. PubMed ID: 10812273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphotericin B lipid complex therapy in an AIDS patient with Rhodotorula rubra fungemia.
    Lui AY; Turett GS; Karter DL; Bellman PC; Kislak JW
    Clin Infect Dis; 1998 Oct; 27(4):892-3. PubMed ID: 9798050
    [No Abstract]   [Full Text] [Related]  

  • 35. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fungemia caused by Verticillium species in an immunocompromised child.
    Bashir G; Thokar MA; Ahmad S; Fomda BA; Lone R; Fazili T
    Indian J Med Microbiol; 2006 Jan; 24(1):65-6. PubMed ID: 16505562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
    Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
    Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece.
    Christakis G; Perlorentzou S; Aslanidou M; Megalakaki A; Velegraki A
    Mycoses; 2005 May; 48(3):216-20. PubMed ID: 15842341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic review.
    Tuon FF; de Almeida GM; Costa SF
    Med Mycol; 2007 Aug; 45(5):441-7. PubMed ID: 17654271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.